Literature DB >> 30411210

CPEB1 Expression Correlates with Severity of Posttraumatic Ankle Osteoarthritis and Aggravates Catabolic Effect of IL-1β on Chondrocytes.

Lei Li1, Jiaping Lan2, Yongjie Ye2, Bo Yang2, Xiaoyong Yang3, Zhijun Cai3.   

Abstract

Most cases of posttraumatic ankle osteoarthritis (PTAOA) represent a sequela of ankle fractures. The cytoplasmic polyadenylation element-binding protein 1 (CPEB1) is an RNA binding protein that controls protein expression. Here, we report the previously unappreciated association of CPEB1 with PTAOA. We found that CPEB1 was upregulated in articular cartilage from patients with PTAOA. Additionally, its expression level positively correlated with disease severity. In human primary chondrocytes cultured in vitro, CPEB1 was upregulated when treated with pro-inflammatory cytokines, i.e., IL-1β and TNF-α, suggesting that the observed CPEB1 upregulation in articular cartilage of PTAOA patients may be attributed to local inflammatory milieu. Functionally, CPEB1 overexpression aggravated the catabolic effect of IL-1β on chondrocytes in vitro, and vice versa, its knockdown reduced this effect, together implying a detrimental role of CPEB1 involved in OA progression. In sum, our study identifies CPEB1 as a potential regulator of disease progression of PTAOA.

Entities:  

Keywords:  CPEB1; IL-1β; catabolism; chondrocyte; correlation; posttraumatic ankle osteoarthritis

Mesh:

Substances:

Year:  2019        PMID: 30411210     DOI: 10.1007/s10753-018-0920-6

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  2 in total

1.  miR-129-3p alleviates chondrocyte apoptosis in knee joint fracture-induced osteoarthritis through CPEB1.

Authors:  Ruixiong Chen; Baoqing Ye; Han Xie; Yuliang Huang; Zhehui Wu; Hongbo Wu; Xiaofeng Wang; Haixiong Miao; Weiguo Liang
Journal:  J Orthop Surg Res       Date:  2020-11-23       Impact factor: 2.359

Review 2.  RNA binding proteins in osteoarthritis.

Authors:  Qian Yi; Zhenhan Deng; Jiaji Yue; Jinglong He; Jianyi Xiong; Wei Sun; Weichao Sun
Journal:  Front Cell Dev Biol       Date:  2022-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.